Literature DB >> 19462469

Miscibility/stability considerations in binary solid dispersion systems composed of functional excipients towards the design of multi-component amorphous systems.

Seung-uk Yoo1, Steven L Krill, Zeren Wang, Chitra Telang.   

Abstract

The correlations between amorphous miscibility/physical stability of binary solid dispersions (a highly crystalline additive-an amorphous polymer) and the physicochemical properties of the components were investigated. Crystalline functional excipients including surfactants, organic acids, and organic bases were prepared in binary solid dispersions in amorphous polymers by solvent evaporation method. Amorphous miscibility and physical stability of the systems were characterized using polarized light microscope, differential scanning calorimeter, and powder X-ray diffraction. Physicochemical parameters (solubility parameter (delta), hydrogen bond energy, Log P, pK(a) value as an indicator of acid-base ionic interaction, and T(g) of the dispersion as a surrogate of system's mobility) were selected as thermodynamic and kinetic factors to examine their influences on the systems' amorphous miscibility and physical stability. All systems possessing acid-base ionic interaction formed amorphous state. In the absence of the ionic interaction, solubility parameter and partition coefficient were shown to have major roles on amorphous formation. Upon storage condition at 25 degrees C/60% RH for 50 days, systems having ionic interaction and high T(g) remained in the amorphous state. This binary system study provides an insight and a basis for formation of the amorphous state of multi-component solid dispersions utilizing their physicochemical properties. 2009 Wiley-Liss, Inc. and the American Pharmacists Association

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19462469     DOI: 10.1002/jps.21779

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  8 in total

1.  A systematic approach to design and prepare solid dispersions of poorly water-soluble drug.

Authors:  Sanjay Verma; Varma S Rudraraju
Journal:  AAPS PharmSciTech       Date:  2014-02-22       Impact factor: 3.246

Review 2.  Hot-Melt Extrusion: a Roadmap for Product Development.

Authors:  Marta F Simões; Rui M A Pinto; Sérgio Simões
Journal:  AAPS PharmSciTech       Date:  2021-06-17       Impact factor: 3.246

Review 3.  Physical Stability of Amorphous Solid Dispersions: a Physicochemical Perspective with Thermodynamic, Kinetic and Environmental Aspects.

Authors:  Xia Lin; Yang Hu; Lei Liu; Lili Su; Na Li; Jing Yu; Bo Tang; Ziyi Yang
Journal:  Pharm Res       Date:  2018-04-23       Impact factor: 4.200

4.  An Insight into Eudragit S100 Preserving Mechanism of Cinnarizine Supersaturation.

Authors:  Maryam Maghsoodi; Saeideh Mollaie Astemal; Ali Nokhodchi; Hossein Kiaie; Ali Baradar Khoshfetrat; Fatemeh Talebi
Journal:  AAPS PharmSciTech       Date:  2022-03-01       Impact factor: 3.246

5.  Assessing Mixing Quality of a Copovidone-TPGS Hot Melt Extrusion Process with Atomic Force Microscopy and Differential Scanning Calorimetry.

Authors:  Matthew S Lamm; James DiNunzio; Nazia N Khawaja; Louis S Crocker; Anthony Pecora
Journal:  AAPS PharmSciTech       Date:  2015-08-18       Impact factor: 3.246

Review 6.  Using X-ray Diffraction Techniques for Biomimetic Drug Development, Formulation, and Polymorphic Characterization.

Authors:  Israel Rodríguez; Ritika Gautam; Arthur D Tinoco
Journal:  Biomimetics (Basel)       Date:  2020-12-30

7.  Formulating a heat- and shear-labile drug in an amorphous solid dispersion: Balancing drug degradation and crystallinity.

Authors:  Daniel A Davis; Dave A Miller; Supawan Santitewagun; J Axel Zeitler; Yongchao Su; Robert O Williams
Journal:  Int J Pharm X       Date:  2021-07-17

8.  Relative Contributions of Solubility and Mobility to the Stability of Amorphous Solid Dispersions of Poorly Soluble Drugs: A Molecular Dynamics Simulation Study.

Authors:  Michael Brunsteiner; Johannes Khinast; Amrit Paudel
Journal:  Pharmaceutics       Date:  2018-07-21       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.